86 related articles for article (PubMed ID: 20232390)
1. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.
Shi JY; Ren ZH; Jiao B; Xiao R; Yun HY; Chen B; Zhao WL; Zhu Q; Chen Z; Chen SJ
Int J Cancer; 2011 Jan; 128(1):233-8. PubMed ID: 20232390
[TBL] [Abstract][Full Text] [Related]
2. XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients.
El-Tokhy MA; Hussein NA; Bedewy AM; Barakat MR
Hematology; 2014 Oct; 19(7):397-403. PubMed ID: 24284041
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
6. Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Meier M; den Boer ML; Hall AG; Irving JA; Passier M; Minto L; van Wering ER; Janka-Schaub GE; Pieters R
Leukemia; 2005 Nov; 19(11):1887-95. PubMed ID: 16167060
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
8. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
[TBL] [Abstract][Full Text] [Related]
9. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.
Su D; Ma S; Liu P; Jiang Z; Lv W; Zhang Y; Deng Q; Smith S; Yu H
Lung Cancer; 2007 May; 56(2):281-8. PubMed ID: 17222938
[TBL] [Abstract][Full Text] [Related]
11. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.
Zschenker O; Raabe A; Boeckelmann IK; Borstelmann S; Szymczak S; Wellek S; Rades D; Hoeller U; Ziegler A; Dikomey E; Borgmann K
Radiother Oncol; 2010 Oct; 97(1):26-32. PubMed ID: 20170971
[TBL] [Abstract][Full Text] [Related]
12. Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population.
Liang G; Xing D; Miao X; Tan W; Yu C; Lu W; Lin D
Int J Cancer; 2003 Jul; 105(5):669-73. PubMed ID: 12740916
[TBL] [Abstract][Full Text] [Related]
13. The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays.
Gdowicz-Klosok A; Widel M; Rzeszowska-Wolny J
Mutat Res; 2013 Jul; 755(1):42-8. PubMed ID: 23669291
[TBL] [Abstract][Full Text] [Related]
14. A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia.
Smith AG; Worrillow LJ; Allan JM
Blood; 2007 Feb; 109(3):1233-6. PubMed ID: 17023576
[TBL] [Abstract][Full Text] [Related]
15. Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients.
Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Gerger S; Zacherl M; Renner W; Haijun M; Leithner A; Gerger A
Cancer Epidemiol; 2013 Dec; 37(6):1003-9. PubMed ID: 24189466
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].
Xu W; Li JY; Li L; Wu YJ; Yu H; Shen QD; Qiu HX
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):450-3. PubMed ID: 19035176
[TBL] [Abstract][Full Text] [Related]
18. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
[TBL] [Abstract][Full Text] [Related]
19. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
[TBL] [Abstract][Full Text] [Related]
20. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India.
Pramanik S; Devi S; Chowdhary S; Surendran ST; Krishnamurthi K; Chakrabarti T
Chemosphere; 2011 Feb; 82(7):941-6. PubMed ID: 21183201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
